WILMINGTON, DE — Incyte (Nasdaq: INCY) has expanded its Moments of Clarity program, adding six new personal stories that illuminate the lived experiences of people managing chronic immune-mediated skin conditions, including nonsegmental vitiligo and mild-to-moderate atopic dermatitis (eczema).
The initiative, launched to elevate patient voices, now features narratives that span childhood through adulthood, offering a candid look at the social, emotional, and medical challenges faced by individuals and families. The stories also highlight the importance of seeking medical care and the impact of effective treatment plans, including the use of Opzelura® (ruxolitinib) cream 1.5%, a prescription therapy approved for nonsegmental vitiligo and mild-to-moderate eczema in certain age groups.
This year’s profiles include Sarah, a teacher and mother who has lived with vitiligo for more than 17 years. Her story details the emotional toll of the condition—from cruel comments from strangers to the patient persistence required for repigmentation. She describes her decision to seek treatment as an act of self-advocacy.
Another featured story introduces Adam and his 10-year-old daughter, Piper, whose eczema symptoms reshaped daily life for their family. Adam said finding an effective treatment helped restore stability at home and offered meaningful relief for his daughter.
Matteo Trotta, Executive Vice President and General Manager of U.S. Dermatology at Incyte, said expanding the program allows the company to honor the experiences of those living with chronic skin conditions. He added that sharing real-world stories can empower other patients and caregivers, helping them feel less isolated and more confident in navigating their own care.
Opzelura is approved for short-term, non-continuous chronic treatment of mild-to-moderate eczema in adults and children two and older whose disease is not well controlled with topical prescription therapies, as well as for nonsegmental vitiligo in adults and children aged 12 and older. It is not recommended for use alongside therapeutic biologics, other JAK inhibitors, or strong immunosuppressants.
Incyte says the expanded Moments of Clarity program aims to build community, improve understanding, and encourage individuals to seek support as they navigate the complexities of chronic skin conditions.
Stories from the initiative can be viewed at MyMomentsOfClarity.com.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.